Method of treatment of small for gestational age infants under two years of age
AssigneeMor Research Applications Ltd.
InventorZvi Laron
Life of this patent
Estimating the term…
Abstract
The invention provides a method and a composition for the treatment of infants age less than 2.5 years old defined as small for gestational age (SGA), including the use of hGH or any compound that increases blood levels of hGH or of IGF-I. Early use of the composition prevents the irreversible neurological and psychological damage of the children.
Claims11
A method for the treatment, amelioration, delaying the onset or prophylaxis of small-for-gestational-age (SGA)-associated disorders, diseases, conditions and sequelae, the method comprising the step of administering to an SGA human subject in need thereof a therapeutically effective amount of at least one compound selected from the group consisting of growth hormone (GH), a GH functional fragment, a GH functional mutant, Insulin-like growth factor-I (IGF-I), GH releasing hormone (GHRH), GH releasing peptide 2 (GHRH-2), GH releasing peptide 6 (GHRH-6), Hexarelin, Ghrelin, triiodothyronine (T3), testosterone, isoflavones, capsaicin, casein, bovine colostrum and zinc, wherein said administration is initiated when said human subject is under two years of age.
Dependencies are inferred from the claim text.